Learn, Adapt, Conquer – Conversations with Vitaliy – Ep 20
Jan 3, 2024
auto_awesome
Reflecting on the struggles and successes of investing in a controversial video game company. Analysis of Berkshire Hathaway's investment in McKesson and the impact of Amazon's entry into the pharmacy business. Lessons from investing in different stocks in the pharmaceutical and technology industries.
Do not let emotions drive investment decisions and evaluate the long-term worth of a company during the painful parts of the investment journey.
Staying invested in undervalued companies despite short-term challenges can lead to significant returns in the long run.
Deep dives
Lesson from Investing in Electronic Corrants
One of the main lessons learned from the podcast episode is the importance of not letting emotions dictate investment decisions. The speaker shares the example of buying a controversial stock called Electronic Corrants, which was named the worst company in America at the time. Despite a good initial thesis on the company's transition from analog to digital, the stock value halved and then doubled, leading the speaker to sell for a victory. However, the stock price then quadrupled over the next few years, highlighting the mistake of not staying invested as the original thesis was just starting to play out. The lesson is to zoom out during the painful parts of the investment journey and evaluate the company's long-term worth.
Staying Invested in Companies Like McKesson
The podcast episode also emphasizes the importance of staying invested in undervalued companies despite short-term challenges. McKesson, a major drug distributor, was initially owned by growth investors, resulting in a decline in stock value when the growth slowed down. However, the speaker believed in the company's future potential and bought it during this transitional phase. Despite the stock price declining further due to lawsuits against the drug industry, the speaker held onto the stock, knowing the long-term cash flows hadn't changed. Eventually, the lawsuits were settled, and the stock tripled in value. This experience teaches the lesson that being stubborn when a company is undervalued can lead to significant returns in the long run.
WHO AM I: Vitaliy Katsenelson is the CEO of Investment Management Associates (IMA) in 2012. Forbes Magazine called him “The New Benjamin Graham.” He’s written for publications including Financial Times, Barron’s, Institutional Investor, and Foreign Policy.